Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286511468> ?p ?o ?g. }
- W4286511468 endingPage "542" @default.
- W4286511468 startingPage "535" @default.
- W4286511468 abstract "To describe the characteristics of the body components and phase angle of patients with MAFLD according to those different to fibrosis and hepatic steatosis. Observational and descriptive study in a cohort of 585 volunteers from our center with MAFLD criteria. The risk of liver fibrosis was determined by APRI, NAFLD score and FIB-4; at an indeterminate and high risk of fibrosis, a transient elastography (Fibroscan) were realize. Bioimpedance body composition analysis (SECA®) was performed. Patients with ET and SECA® registry were included. Bioimpedance body composition analysis (SECA®) was performed. Patients with ET and SECA® registry were included. 125 participants (21.4%) were evaluated, age 53.9 ± 13.9 years, 62.1% women, BMI 33.2 ± 5.8 kg/m 2 . The SECA® analysis showed mean fat mass of 42% ± 7.32 and muscle mass 21.18 kg ± 6.6. The PhA was 5.1 ± 0.69, in women 4.92 ± 0.62 and men 5.41 ± 0.70. PhA in patients without fibrosis was 5091 vs with fibrosis 5121, ( P = .813). In advanced fibrosis, it reported a low value compared to the rest of the groups ( P = .031). The PhA in S3 was higher compared to S1 and S2 (5.3 vs 4.82, 4.81) ( P = .027). In MAFLD the PhA was lower than the healthy Mexican population. In patients without fibrosis and severe steatosis, PhA rises proportionally to the increase in fat mass and BMI and in advanced liver fibrosis, PhA decreases. Describir las características de la composición corporal y ángulo de fase (AF) en pacientes con MAFLD de acuerdo fibrosis y esteatosis hepática. Estudio transversal, observacional y descriptivo en una cohorte de 585 voluntarios de nuestro centro con criterios de MAFLD. El riesgo de fibrosis hepática se determinó por APRI, NAFLD score y FIB-4; en riesgo indeterminado y elevado de fibrosis se realizó elastrografía hepática de transición (ET) con Fibroscan®. Se realizó análisis de la composición corporal por bioimpedancia (SECA®). Se incluyeron pacientes con registro de ET y SECA®. Se evaluaron 125 participantes (21.4%), edad 53.9 ± 13.9 años, 62.1% mujeres, IMC 33.2 ± 5.8 kg/m 2 . El análisis SECA® mostró media de masa grasa de 42% ± 7.32 y masa muscular 21.18 kg ± 6.6. El ángulo de fase fue 5.1 ± 0.69, en mujeres 4.92 ± 0.62 y hombres 5.41 ± 0.70. El AF en pacientes sin fibrosis fue 5.091 vs con fibrosis 5.121, ( P = .813). En fibrosis avanzada se reportó valor bajo en comparación con el resto de los grupos ( P = .031). El AF en S3 fue mayor en comparación con S1 y S2 (5.3 vs 4.82, 4.81) ( P = .027). En MAFLD el AF fue menor vs población sana mexicana. Pacientes sin fibrosis y esteatosis severa el AF se eleva proporcional al incremento de masa grasa e IMC y en fibrosis hepática avanzada el AF disminuye." @default.
- W4286511468 created "2022-07-22" @default.
- W4286511468 creator A5000143027 @default.
- W4286511468 creator A5003647328 @default.
- W4286511468 creator A5007753554 @default.
- W4286511468 creator A5018967021 @default.
- W4286511468 creator A5021247344 @default.
- W4286511468 creator A5030347329 @default.
- W4286511468 creator A5032534340 @default.
- W4286511468 creator A5037746101 @default.
- W4286511468 creator A5040882572 @default.
- W4286511468 creator A5051722679 @default.
- W4286511468 creator A5077751770 @default.
- W4286511468 creator A5081510457 @default.
- W4286511468 creator A5085105793 @default.
- W4286511468 creator A5085110091 @default.
- W4286511468 creator A5085664035 @default.
- W4286511468 creator A5087973912 @default.
- W4286511468 creator A5091863519 @default.
- W4286511468 date "2022-08-01" @default.
- W4286511468 modified "2023-10-16" @default.
- W4286511468 title "Body composition and phase angle by bioimpedance in patients with MAFLD" @default.
- W4286511468 cites W1252504093 @default.
- W4286511468 cites W2021338429 @default.
- W4286511468 cites W2032959495 @default.
- W4286511468 cites W2056594824 @default.
- W4286511468 cites W2082211146 @default.
- W4286511468 cites W2100305910 @default.
- W4286511468 cites W2612547579 @default.
- W4286511468 cites W2909512208 @default.
- W4286511468 cites W2969841699 @default.
- W4286511468 cites W3004644667 @default.
- W4286511468 cites W3047275661 @default.
- W4286511468 cites W3082337553 @default.
- W4286511468 cites W3107125656 @default.
- W4286511468 cites W3132153535 @default.
- W4286511468 cites W3156151084 @default.
- W4286511468 cites W4243497973 @default.
- W4286511468 cites W4255712601 @default.
- W4286511468 doi "https://doi.org/10.1016/j.gastre.2021.10.004" @default.
- W4286511468 hasPublicationYear "2022" @default.
- W4286511468 type Work @default.
- W4286511468 citedByCount "0" @default.
- W4286511468 crossrefType "journal-article" @default.
- W4286511468 hasAuthorship W4286511468A5000143027 @default.
- W4286511468 hasAuthorship W4286511468A5003647328 @default.
- W4286511468 hasAuthorship W4286511468A5007753554 @default.
- W4286511468 hasAuthorship W4286511468A5018967021 @default.
- W4286511468 hasAuthorship W4286511468A5021247344 @default.
- W4286511468 hasAuthorship W4286511468A5030347329 @default.
- W4286511468 hasAuthorship W4286511468A5032534340 @default.
- W4286511468 hasAuthorship W4286511468A5037746101 @default.
- W4286511468 hasAuthorship W4286511468A5040882572 @default.
- W4286511468 hasAuthorship W4286511468A5051722679 @default.
- W4286511468 hasAuthorship W4286511468A5077751770 @default.
- W4286511468 hasAuthorship W4286511468A5081510457 @default.
- W4286511468 hasAuthorship W4286511468A5085105793 @default.
- W4286511468 hasAuthorship W4286511468A5085110091 @default.
- W4286511468 hasAuthorship W4286511468A5085664035 @default.
- W4286511468 hasAuthorship W4286511468A5087973912 @default.
- W4286511468 hasAuthorship W4286511468A5091863519 @default.
- W4286511468 hasConcept C120665830 @default.
- W4286511468 hasConcept C121332964 @default.
- W4286511468 hasConcept C124952713 @default.
- W4286511468 hasConcept C136229726 @default.
- W4286511468 hasConcept C142362112 @default.
- W4286511468 hasConcept C170222088 @default.
- W4286511468 hasConcept C178790620 @default.
- W4286511468 hasConcept C185592680 @default.
- W4286511468 hasConcept C192562407 @default.
- W4286511468 hasConcept C40231798 @default.
- W4286511468 hasConcept C44280652 @default.
- W4286511468 hasConcept C71924100 @default.
- W4286511468 hasConceptScore W4286511468C120665830 @default.
- W4286511468 hasConceptScore W4286511468C121332964 @default.
- W4286511468 hasConceptScore W4286511468C124952713 @default.
- W4286511468 hasConceptScore W4286511468C136229726 @default.
- W4286511468 hasConceptScore W4286511468C142362112 @default.
- W4286511468 hasConceptScore W4286511468C170222088 @default.
- W4286511468 hasConceptScore W4286511468C178790620 @default.
- W4286511468 hasConceptScore W4286511468C185592680 @default.
- W4286511468 hasConceptScore W4286511468C192562407 @default.
- W4286511468 hasConceptScore W4286511468C40231798 @default.
- W4286511468 hasConceptScore W4286511468C44280652 @default.
- W4286511468 hasConceptScore W4286511468C71924100 @default.
- W4286511468 hasIssue "7" @default.
- W4286511468 hasLocation W42865114681 @default.
- W4286511468 hasOpenAccess W4286511468 @default.
- W4286511468 hasPrimaryLocation W42865114681 @default.
- W4286511468 hasRelatedWork W1930805725 @default.
- W4286511468 hasRelatedWork W2062202252 @default.
- W4286511468 hasRelatedWork W2168780059 @default.
- W4286511468 hasRelatedWork W2332359119 @default.
- W4286511468 hasRelatedWork W2356020885 @default.
- W4286511468 hasRelatedWork W2358313471 @default.
- W4286511468 hasRelatedWork W2898075043 @default.
- W4286511468 hasRelatedWork W2899084033 @default.
- W4286511468 hasRelatedWork W2999610367 @default.